Let's aim for
$100m up front payment for the Trials
$1B payment for Licensing if Trials successful
40% royalty going forward for the life of the combined Patent.
No restrictions on being able to license it for any other Drug combination.
Rinse repeat for every Cancer drug on the market... YES PLEASE!
- Forums
- ASX - By Stock
- RAC
- Ann: Expanded Heart Protection Discovery for Zantrene
Ann: Expanded Heart Protection Discovery for Zantrene, page-95
-
-
- There are more pages in this discussion • 292 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$2.02 |
Change
0.010(0.50%) |
Mkt cap ! $343.9M |
Open | High | Low | Value | Volume |
$2.04 | $2.09 | $1.92 | $768.4K | 380.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 484 | $2.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.02 | 3251 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 484 | 2.000 |
1 | 2319 | 1.985 |
1 | 252 | 1.980 |
1 | 16000 | 1.975 |
2 | 6132 | 1.970 |
Price($) | Vol. | No. |
---|---|---|
2.020 | 3251 | 2 |
2.040 | 500 | 1 |
2.050 | 10000 | 1 |
2.070 | 994 | 1 |
2.080 | 2450 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online